Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A New Agent for the Treatment of Candidal Vaginitis

A New Agent for the Treatment of Candidal Vaginitis Candicidin is an antibiotic that is effective topically in the treatment of candidal vaginitis. Although it has an antifungal spectrum similar to that of amphotericin B (Fungizone), it is not absorbed systemically. Adverse reactions occur infrequently and are mild. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

A New Agent for the Treatment of Candidal Vaginitis

JAMA , Volume 196 (13) – Jun 27, 1966

A New Agent for the Treatment of Candidal Vaginitis

Abstract


Candicidin is an antibiotic that is effective topically in the treatment of candidal vaginitis. Although it has an antifungal spectrum similar to that of amphotericin B (Fungizone), it is not absorbed systemically. Adverse reactions occur infrequently and are mild.
Loading next page...
 
/lp/american-medical-association/a-new-agent-for-the-treatment-of-candidal-vaginitis-rDhK64r6Z5

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1966 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1966.03100260082023
Publisher site
See Article on Publisher Site

Abstract

Candicidin is an antibiotic that is effective topically in the treatment of candidal vaginitis. Although it has an antifungal spectrum similar to that of amphotericin B (Fungizone), it is not absorbed systemically. Adverse reactions occur infrequently and are mild.

Journal

JAMAAmerican Medical Association

Published: Jun 27, 1966

There are no references for this article.